CBD wholesaler in France: 5 checks before you order
When you buy CBD wholesale to resell it, you answer for what you sell. Five points can be checked on documents before ordering: a variety listed in an official catalogue, certified seeds, a Δ⁹-THC content of no more than 0.30% including in extracts and finished products, non-food use, and an analysis from a laboratory accredited for that measurement. You can verify every one of them without relying on the supplier's word.
Key takeaways
- Under the order of 30 December 2021, the variety must be in the EU or French catalogue and the seeds must be certified.
- Extracts, and any product containing them, are subject to the same 0.30% Δ⁹-THC cap.
- The Conseil d'État's 2022 annulment covered only the ban on selling raw flowers and leaves, and the rest of the order remains in force.
- The Ministry of Agriculture's reminder of 20 May 2026 confirms that no CBD food is authorised, supplements included.
- An accreditation number means little until you check the scope it covers.
The applicable text and what it covers
The legal basis is the order of 30 December 2021, adopted to apply article R. 5132-86 of the Public Health Code. Article 1, paragraph I, authorises only varieties of Cannabis sativa L. whose Δ⁹-THC content does not exceed 0.30%. These varieties must also be listed in the EU common catalogue of varieties of agricultural plant species or in the official French catalogue.
The authorisation comes with three conditions that buyers often overlook. Flowers and leaves have to come from certified seeds, only active farmers may grow them, and the sale of plants and the taking of cuttings are still prohibited.
Most of the commercial risk lies in paragraph III: "The delta-9-tetrahydrocannabinol content of hemp extracts, and of the products that incorporate them, shall not exceed 0.30%." The cap thus reaches beyond raw flowers, to the extract itself and to every finished product containing it.
France carries particular weight in this sector. The European Commission's hemp page puts its share at more than 60% of EU hemp production, and 116 varieties were listed in the common catalogue in 2024. Your supplier should be able to tell you which one they use.
What the Conseil d'État annulled, and what it left standing
Trade publications often misreport this point. In its decision no. 444887 of 29 December 2022, the Conseil d'État, France's highest administrative court, annulled one provision of the order: paragraph II of article 1. That paragraph reserved flowers and leaves for industrial extraction and banned their sale to consumers. The rest of the order was not annulled.
The litigation thus left the variety rule, the certified-seed requirement and the 0.30% cap on extracts intact. A supplier who describes the decision as a general liberalisation is misstating the law.
The reasoning is set out in the Conseil d'État's press release: CBD "has no psychotropic effect and does not cause dependence". The decision adds that the THC content of flowers can be checked "by means of quick and inexpensive tests". Analytical proof was therefore part of the court's own reasoning.
Food status, the dividing line for stock
Food status is now where the largest risk lies. In a notice of 20 May 2026, the Ministry of Agriculture reminds businesses that foods with CBD among their ingredients are not authorised under Regulation (EU) 2015/2283 on novel foods. Their safety has not been demonstrated.
Two categories remain lawful as food: hemp seeds and their derivatives, seed oil included, and leaves intended solely for aqueous infusion. Cannabinoid extracts may not be added to either. Through the departmental anti-fraud operational committees, the ministry is extending checks to every food that puts CBD forward, supplements and online sales included.
The checks apply a rule that was already in force, so gummies or supplements bought before 2026 were never lawful as food either. On 9 February 2026, the EFSA published a provisional safe level of 0.0275 mg per kilo of body weight per day, about 2 mg for an adult of 70 kg. That figure is an assessment benchmark and authorises nothing. Our guide to CBD regulation in 2026 covers this shift in detail.
Wholesale trade can still deal in flowers, resins, non-food extracts, vaping products and cosmetics, each under its own rules.
The certificate of analysis: proof, if you check it
If the laboratory cannot be identified, the certificate proves nothing. Decree no. 2008-1401 of 19 December 2008 names the French accreditation committee (COFRAC) as the national accreditation body. Testing laboratories are accredited against the NF EN ISO/IEC 17025 standard, which covers both technical competence and impartiality.
Buyers seldom make two checks. Write down the accreditation number, then make sure the scope includes quantifying cannabinoids in the matrix in question, whether flower, resin or oil. Each accreditation is valid only for its defined scope. Our article on a laboratory's accreditation scope shows where to find it.
The order itself does not require an accredited laboratory. An accredited analysis is how you prove compliance with the 0.30% cap; it is not a separate obligation. The lines to check are detailed in our guide to reading a certificate of analysis, and the measurement methods are described on the laboratory page.
The checklist, document by document
| Point to check | Document to request | What it must show | Text |
|---|---|---|---|
| Authorised variety | Variety name, seed invoice | Listing in the EU or French catalogue | Order of 30 Dec. 2021, art. 1, I |
| Certified seeds | Seed labels or certificates | Official certification of the seed lot | Order of 30 Dec. 2021, art. 1, I |
| Δ⁹-THC ≤ 0.30% | Certificate of analysis for the delivered batch | Same batch number, result in %, method | Order of 30 Dec. 2021, art. 1, III |
| Non-food use | Product sheet, label | No mention of ingestion or supplements | Regulation (EU) 2015/2283 |
| Competent laboratory | COFRAC accreditation number | Scope covering cannabinoids in that matrix | Decree no. 2008-1401 |
All these documents must refer to the same batch. A certificate issued for another batch or another product tells you nothing about the goods delivered. For resins, our article on solvents in hash shows what a certificate can reveal. The formats concerned are illustrated by the CBD flowers and resins in the catalogue.
What the law does not say
We found no authorisation scheme specific to the CBD trade in the official sources we consulted. That conclusion comes from documentary research and is no legal guarantee. Our article on opening a shop gathers the other factors, and online shops are covered in our article on the notices a CBD website must display.
French and EU law contain no legal grading of flower quality, and commercial labels for size or range have no regulatory effect. For goods arriving from another country, our article on customs and CBD parcels describes the applicable checks.
Frequently asked questions
None of the official sources consulted sets up an authorisation scheme specific to CBD. The obligations bear on the product: a variety from the catalogue, certified seeds, no more than 0.30% Δ⁹-THC, and respect for food status.
No. The Ministry of Agriculture reminded businesses on 20 May 2026 that foods containing CBD are not authorised under Regulation (EU) 2015/2283. Hemp seeds, their derivatives and leaves for aqueous infusion are the only lawful exceptions, and only with no added cannabinoids.
Yes. Paragraph III of article 1 of the order of 30 December 2021 explicitly covers hemp extracts and the products that incorporate them, and the Conseil d'État left it in place in 2022.
Only when it bears the number of the batch delivered and comes from a laboratory accredited for cannabinoids in that matrix. A generic certificate, or one issued for a different batch, proves nothing about the goods you received.
Written by the Phytogrammes team
Each journal article draws on cited primary sources: ANSM, EFSA, EUR-Lex and peer-reviewed publications. Product profiles are distinguished from documented laboratory results. Our approach.
Article published on . CBD is not a medicine.